Firm News

Big Pharma Big Greed

  When: Tuesday, April 23, 2019 Time: 5:30 PM Location: Shakespeare & Co., 1632 Walnut Street, Philadelphia, PA 19103 Description: Big Pharma, Big Greed: The Inside Story of One Lawyer’s Battle to Stem
Screen-Shot-2019-01-25-at-3.34.17-PM

The controversial Philadelphia Police Department ‘Live Stop’ policy makes headlines again as local resident and criminal justice activist, Reuben Jones, was left on the side of the road in the extreme cold with his
PA Superior Court Logo

The Pennsylvania Superior Court has upheld the 2015 $2.5 million Risperdal verdict for plaintiff Austin Pledger. Pledger’s case was the first Risperdal case to go to trial. Viewed as a huge win for
(FILES)This undated handout photo receiv

After years of litigation and several court losses for harm caused by Risperdal, Johnson & Johnson’s legal team agreed to settle the suit of a young boy from Mississippi who claims he developed female-like
legal_examiner_small

The PA Supreme Court has agreed to review a Superior Court decision which would dismiss thousands of Risperdal cases due to statute of limitations. The two cases on appeal, Saksek v. Janssen and Winter v. Janssen,
(FILES)This undated handout photo receiv

Philadelphia Court of Common Pleas Judge Paula Patrick urges the Pennsylvania Superior Court to uphold the $70 Million jury verdict in A.Y. v. Janssen Pharmaceuticals. AY is one of many boys who developed
Superlawyers 2018 Cropped

Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive year. Attorneys Kimberly A. Aponte Borden and Jamie
images

Sheller PC’s founder, Stephen Sheller, joined other litigators, judges and state prosecutors at a conference to discuss the legal response to the opioid crisis. The forum was hosted by University of Pennsylvania Law
city-of-philadelphia-logo

Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid crisis. Five
legal,intelligencer

In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling